EdgarLookup

Alkermes plc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 3,748 $30.00 $112,440 65,740 Dec 3, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 4,000 $29.30 $117,200 65,740 Dec 1, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Option Exercise 5,000 $19.34 $96,700 78,740 Nov 3, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 9,000 $31.53 $283,770 73,740 Oct 15, 2025
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Option Exercise 2,014 206,269 Aug 3, 2025
Nichols Christian Todd SVP, Chief Commercial Officer Sale 3,333 $31.95 $106,489 89,542 Jun 10, 2025
Wright Christopher I Tax Withholding 793 $31.71 $25,146 23,013 Jun 8, 2025
Wright Christopher I Option Exercise 8,013 22,429 May 31, 2025
Wilson Frank Anders Tax Withholding 1,924 $30.61 $58,894 31,084 May 31, 2025
snyderman nancy lynn MD Tax Withholding 1,924 $30.61 $58,894 10,728 May 31, 2025
MCKEON BRIAN P Tax Withholding 1,924 $30.61 $58,894 33,869 May 31, 2025
Lurker Nancy Tax Withholding 1,924 $30.61 $58,894 10,705 May 31, 2025
LAURENCIN CATO T Option Exercise 8,013 31,026 May 31, 2025
GAYNOR RICHARD Option Exercise 8,013 33,008 May 31, 2025
Cooke Shane Tax Withholding 4,175 $30.61 $127,797 103,744 May 31, 2025
Lurker Nancy Tax Withholding 558 $27.00 $15,066 1,765 Apr 11, 2025
Parisi Samuel Joseph VP, Finance (Interim PAO) Sale 1,938 $34.00 $65,892 7,717 Feb 26, 2025
Nichols Christian Todd SVP, Chief Commercial Officer Tax Withholding 2,402 $34.80 $83,590 92,875 Feb 26, 2025
Jackson Blair Curtis EVP, Chief Operating Officer Tax Withholding 3,695 $34.80 $128,586 201,368 Feb 26, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Option Exercise 6,866 80,789 Feb 26, 2025
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Tax Withholding 3,049 $34.80 $106,105 204,255 Feb 26, 2025
Brown Iain Michael SVP, Chief Financial Officer Tax Withholding 2,494 $34.80 $86,791 148,196 Feb 26, 2025
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Tax Withholding 3,300 $35.32 $116,556 196,163 Feb 22, 2025
Jackson Blair Curtis EVP, Chief Operating Officer Tax Withholding 3,880 $35.32 $137,042 196,741 Feb 22, 2025
Parisi Samuel Joseph VP, Finance (Interim PAO) Sale 3,743 $35.26 $131,978 7,717 Feb 22, 2025
Brown Iain Michael SVP, Chief Financial Officer Option Exercise 7,109 144,989 Feb 22, 2025
Nichols Christian Todd SVP, Chief Commercial Officer Option Exercise 7,109 89,463 Feb 22, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Tax Withholding 5,452 $35.32 $192,565 69,648 Feb 22, 2025
Parisi Samuel Joseph VP, Finance (Interim PAO) Option Exercise 2,033 9,750 Feb 20, 2025
Nichols Christian Todd SVP, Chief Commercial Officer Option Exercise 6,354 84,223 Feb 18, 2025
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Option Exercise 6,354 194,853 Feb 18, 2025
Brown Iain Michael SVP, Chief Financial Officer Tax Withholding 1,869 $35.90 $67,097 137,880 Feb 18, 2025
Jackson Blair Curtis EVP, Chief Operating Officer Tax Withholding 3,950 $35.90 $141,805 186,494 Feb 18, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Tax Withholding 3,950 $35.90 $141,805 62,821 Feb 18, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 33,108 $33.27 $1,101,503 57,875 Feb 12, 2025
POPS RICHARD F Director and CEO, Alkermes plc Award / Grant 190,640 1,370,315 Feb 6, 2025
Nichols Christian Todd SVP, Chief Commercial Officer Award / Grant 24,565 85,268 Feb 6, 2025
Jackson Blair Curtis EVP, Chief Operating Officer Award / Grant 34,393 192,195 Feb 6, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Award / Grant 34,393 78,683 Feb 6, 2025
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Tax Withholding 9,752 $31.39 $306,115 188,499 Feb 6, 2025
Brown Iain Michael SVP, Chief Financial Officer Tax Withholding 7,514 $31.39 $235,864 133,395 Feb 6, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Option Exercise 29,156 $20.03 $583,995 76,732 Jan 30, 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer Option Exercise 12,452 $20.03 $249,414 72,182 Dec 9, 2024
LAURENCIN CATO T Sale 2,691 $31.85 $85,708 23,013 Dec 8, 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 9,221 $31.50 $290,462 59,730 Dec 5, 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 14,349 $30.77 $441,519 68,951 Dec 4, 2024
Nichols Christian Todd SVP, Chief Commercial Officer Sale 5,208 $29.15 $151,813 60,703 Nov 27, 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 58,996 $30.08 $1,774,600 83,300 Nov 11, 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale 10,471 $29.53 $309,209 99,238 Nov 6, 2024
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Tax Withholding 895 $27.72 $24,809 165,901 Aug 3, 2024